Home > Boards > US Listed > Biotechs > Acadia Pharmaceuticals Inc. (ACAD)

FYI, the "infrastructure" bill failed, apparently due to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
gi197845 Member Profile
 
Followed By 4
Posts 2,659
Boards Moderated 1
Alias Born 08/16/16
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2021 5:34:13 PM
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire - 9/2/2021 9:00:00 AM
Acadia Pharmaceuticals Announces Executive Leadership Change Business Wire - 9/1/2021 4:05:00 PM
Dermata therapeutics appoints Kyri Van Hoose as CFO Seeking Alpha - 9/1/2021 6:55:32 AM
Acadia Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021 Business Wire - 8/5/2021 4:05:00 PM
DRP Treatment’s Path Ahead Unclear, yet Current Risk/Reward Appears Favorable TipRanks - 8/5/2021 10:55:30 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2021 6:03:49 AM
ACADIA Pharma slides after 2021 guidance lagged expectations Seeking Alpha - 8/4/2021 5:03:42 PM
ACADIA Pharma EPS beats by $0.03, misses on revenue; FY21 guidance lowered Seeking Alpha - 8/4/2021 4:22:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2021 4:17:05 PM
Acadia Pharmaceuticals Reports Second Quarter 2021 Financial Results Business Wire - 8/4/2021 4:05:00 PM
The Street’s Gaze Turns to FDA Meeting’s Outcome on DRP Treatment TipRanks - 8/3/2021 7:30:30 PM
The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis Business Wire - 7/21/2021 5:05:00 PM
Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer’s Asso... Business Wire - 7/14/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2021 5:02:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:43:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:42:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:41:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:40:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:39:45 PM
NUPLAZID® (pimavanserin) Efficacy Data from Open-Label Extension (OLE) Study Published in Parkinsonism and Related Disorders Business Wire - 6/3/2021 11:26:00 AM
NUPLAZID® (pimavanserin) Efficacy Data from Open-Label Extension (OLE) Study Published in Parkinsonism and Related Disorders Business Wire - 6/3/2021 9:00:00 AM
Revised Proxy Soliciting Materials (definitive) (defr14a) Edgar (US Regulatory) - 5/12/2021 4:22:37 PM
Acadia maintains 2021 sales guidance as Q1 net sales rise 18% Seeking Alpha - 5/5/2021 5:14:46 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2021 4:20:21 PM
gi197845   Friday, 08/06/21 01:30:52 PM
Re: None
Post # of 3045 
FYI, the "infrastructure" bill failed, apparently due to no money to pay for it. I'm not here to debate the legitimacy of the infrastructure bill. My point is, that part of its' pork at the bottom of the bill, was to lower drug prices. If the bill had been approved/passed, the Acadia stock price would have even dropped lower and had lower profits and then during Acadia's next Q3 call, they would have had to lower their sales guidance even moreseo, due to lower profits/not being able to sell Nuplazid at a premium...

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences